Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20071792 | 0.77 | REN (0.36) | BCHE | |
| SCHEMBL19345127 | 0.76 | — | — | |
| SCHEMBL27332697 | 0.73 | HDAC1 (0.37) | — | |
| SCHEMBL27332695 | 0.73 | HDAC1 (0.37) | — | |
| SCHEMBL17924933 | 0.72 | MGLL (0.32) | — | |
| SCHEMBL27332716 | 0.71 | HDAC1 (0.35) | BCHE | |
| SCHEMBL27332702 | 0.71 | HDAC1 (0.35) | BCHE | |
| SCHEMBL19749276 | 0.70 | MMP1 (0.33) | BCHE | |
| SCHEMBL19982356 | 0.68 | KMT2A (0.31) | — | |
| SCHEMBL20096964 | 0.67 | LMNA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180149637-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180149637-A1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | FCER2, HTR4, HTR3C | BCHE 3137/4885KCNH2 2273/4885CACNA1I 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.